Cascade genetic testing in hereditary cancer: exploring the boundaries of the Italian legal framework

Despite its clinical value, cascade genetic testing (CGT) in hereditary cancer syndromes remains underutilized for a number of reasons, including ineffective family communication of genetic risk information. Therefore, alternative strategies are being explored to improve CGT uptake rates; one such s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Familial cancer 2025-03, Vol.24 (1), p.9, Article 9
Hauptverfasser:	Varesco, Liliana, Di Tano, Francesco, Monducci, Juri, Sciallero, Stefania, Turchetti, Daniela, Bighin, Claudia, Buzzatti, Giulia, Giannubilo, Irene, Trevisan, Lucia, Battistuzzi, Linda
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomedical and Life Sciences Biomedicine Cancer Research Consent Epidemiology General Data Protection Regulation Genetic Counseling - legislation & jurisprudence Genetic Predisposition to Disease Genetic Privacy - legislation & jurisprudence Genetic screening Genetic testing Genetic Testing - legislation & jurisprudence Health care Human Genetics Humans Informed Consent - legislation & jurisprudence Italy Medical personnel Neoplastic Syndromes, Hereditary - diagnosis Neoplastic Syndromes, Hereditary - genetics Original Article
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!